Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- ;
- ; Newcastle University
- ; University of East Anglia
- ; University of Leeds
- ; University of Reading
- ; University of Southampton
- University of Nottingham
- ; Swansea University
- ; UCL
- ; University of Warwick
- Newcastle University
- Swansea University
- UNIVERSITY OF EAST LONDON
- University of Cambridge
- University of East London
- 5 more »
- « less
-
Field
-
points for drug-discovery. However, methods to interrogate and manipulate PPIs are not well established. Moreover, intrinsically disordered regions – segments of protein with no fixed structure
-
, equipment, and travel related to the project. Overview Machine learning aims to transform the drug discovery landscape through the prediction of potential new therapeutics with unprecedented speed and
-
– [email protected] Project summary Drug discovery pipelines are driven by iterative cycles in which molecules are designed, synthesised, purified and tested. A remarkably limited toolkit of reactions
-
for new drugs to treat AMR pathogens Pseudomonas aeruginosa and Mycobacterium abscessus in the lungs of cystic fibrosis (CF) patients. Mycobacterium abscessus is intrinsically resistant to many drugs
-
PhD Studentship - Extending the Chemical Space of mAb Based Cancer Treatment with DNA Nanostructures
immunology, investigating the synthesis and evaluation of a modular cancer therapy platform. We propose to develop DNA nanopores into a modular platform that allows them to act as a drug carrier to enhance
-
challenges in peptide therapeutics discovery for intracellular targets lies in achieving reliable cell penetration. Unlike Lipinski’s 'rule of five' which can guide small molecule drug design, there is
-
Supervisors: Prof. Reinhard J. Maurer, Prof. Scott Habershon Summary: The drug discovery pipeline involves the screening of many molecules before viable leads are identified. This involves screening
-
will be provided to contribute towards consumables, equipment, and travel related to the project. Overview One of the major challenges in peptide therapeutics discovery for intracellular targets lies in
-
life expectancy, it is extremely rare to grow old in good health and by the age of 85 essentially no individual is disease-free. As such, drug discovery research is focusing on potential interventions
-
or can be synthesized in the laboratory. Understanding the space is vital for natural product and drug discovery, but as yet only a tiny fraction of these so-called ‘small’ molecules has been fully